ether was obtained in a multistep process by DBU induced silylation of 7-TES-13-oxo-baccatin III. The 7-TES-13-oxo-14β-azido-baccatin III was used as a key intermediate for the synthesis of a new family of antitumour taxanes containing amino based functional groups at the C-14 position, such as: 14β-azido, 14β-amino, 14β-amino 1, 14-carbamate, 14β-amino 1, 14-thiocarbamate, and 14β-amino N-tert-butoxycarbonyl-1
碱诱导的7-三乙基甲
硅烷基-(7-
TES-)和7-叔丁氧羰基-(7-BOC-)保护的13-氧代-baccatins的H-14脱质子化反应得到相应的烯醇化物,将其用亲电子氮选择性胺化供体,例如偶氮二
羧酸盐和
甲苯磺酰基
叠氮化物。特别地,
甲苯磺酰基
叠氮化物给出了相应的7-BOC-和7-
TES-13-氧代-14β-
叠氮基-浆果
赤霉素III。或者,通过NaN 3制备最后一种化合物在氧化(
硝酸铈铵)条件下诱导了7-
TES-13-氧-浆果
赤霉素III的13-甲
硅烷基烯醇醚的
叠氮化。13-甲
硅烷基烯醇醚是通过
DBU诱导的7-
TES-13-氧代浆果
赤霉素III的甲
硅烷基化在多步法中获得的。7-
TES-13-oxo-14β-
叠氮基浆果
赤霉素III用作合成新的抗肿瘤
紫杉烷类新化合物的关键中间体,该类抗癌
紫杉烷在C-14位置含有基于
氨基的官能团,例如:14β-
叠氮基, 14β-
氨基,14β-
氨基1,14 -
氨基甲